G1 THERAPEUTICS INC (GTHX)

US3621LQ1099 - Common Stock

4.08  -0.23 (-5.34%)

After market: 4.08 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
31.48M
-30.49%		51.3M
62.96%		82.511M
60.84%		71.265M
-13.63%
EBITDA
YoY % growth
-141.99M
-48.06%		-135.65M
4.47%		-39.014M
71.24%		-34.17M
12.42%
EBIT
YoY % growth
-142.46M
-47.66%		-136.18M
4.41%		-39.527M
70.97%		-35.504M
10.18%
Operating Margin
-452.54%-265.46%-47.91%-49.82%
EPS
YoY % growth
-3.53
-34.22%		-3.39
3.97%		-0.95
71.98%		-0.70
26.19%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.21
60.43%
Revenue
Q2Q % growth		15.564M
20.19%
EBITDA
Q2Q % growth		-11.22MN/AN/AN/AN/A
EBIT
Q2Q % growth		-9.699M
62.33%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.21
71.23%		-0.280.0725.19%
Q3 2023
Q2Q % growth		 -0.35
40.68%		-0.34-0.01-4.30%
Q2 2023
Q2Q % growth		 0.14
115.22%		-0.220.36162.75%
Q1 2023
Q2Q % growth		 -0.53
53.91%		-0.650.1218.81%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 14.873M
45.10%		13.336M1.537M11.53%
Q3 2023
Q2Q % growth		 12.3M
-47.84%		14.513M-2.213M-15.25%
Q2 2023
Q2Q % growth		 42.39M
301.04%		29.478M12.912M43.80%
Q1 2023
Q2Q % growth		 12.95M
87.68%		11.419M1.531M13.41%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 26.04% 7.53% 24.78%
Revenue0% -2.68% 0% 0.39%